About us
Our Science
EC-18 Technology Platform
Potential Therapeutic Indications
CRIOM
CIN
ARS
COVID-19
ICI Combination
NASH
Pipeline
IR/PR
PR
Press Release
Enzychem in the News
Publications
IR
IR Documents
Partner & Collaboration
Contact
About us
Our Science
EC-18 Technology Platform
Potential Therapeutic Indications
CRIOM
CIN
ARS
COVID-19
ICI Combination
NASH
Pipeline
IR/PR
PR
Press Release
Enzychem in the News
Publications
IR
IR Documents
Partner & Collaboration
Contact
About us
Our Science
EC-18 Technology Platform
Potential Therapeutic Indications
CRIOM
CIN
ARS
COVID-19
ICI Combination
NASH
Pipeline
IR/PR
PR
Press Release
Enzychem in the News
Publications
IR
IR Documents
Partner & Collaboration
Contact
News
August 7, 2020
Enzychem in the News
Enzychem Lifesciences’ COVID-19 drug proceeds to phase 2 trial
Previous
Next
